1-6 of 6
Hema Dave
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Identifying Tumor-Specific Immune Response and Biomarkers of High-Risk Hodgkin Lymphoma Patients Treated with and without Brentuximab on Children's Oncology Group Trial AHOD1331

Keri Toner, Hema Dave, Gloria Pezzella, Qinglin Pei, Terzah M. Horton, Kara M. Kelly, Lisa Giulino Roth, Sharon M. Castellino, Catherine M. Bollard
Journal: Blood
Blood (2023) 142 (Supplement 1): 4383.
https://doi.org/10.1182/blood-2023-180791
Published: 2023
Journal Articles

Brentuximab Vedotin As Consolidation Therapy Following Autologous Stem Cell Transplantation in Children and Adolescents with Relapsed/Refractory Hodgkin Lymphoma: A Multi-Center Retrospective Analysis

Christopher J. Forlenza, Jaclyn Rosenzweig, Audrey Mauguen, Ilia Buhtoiarov, Branko Cuglievan, Hema Dave, Rebecca J Deyell, Jaime Flerlage, Anna Franklin, Jennifer Krajewski, Kasey J Leger, Lianna Marks, Robin Norris, Martha Pacheco, Faye Willen, Adam Paul Yan, Paul Harker-Murray, Lisa Giulino Roth
Journal: Blood
Blood (2021) 138 (Supplement 1): 2465.
https://doi.org/10.1182/blood-2021-151808
Published: 2021
Journal Articles

Outcome of Donor-Derived Tumor Associated Antigen-Specific T Cell Therapy in Patients with High-Risk or Relapsed Acute Leukemia Post Allogeneic BMT

Hannah Kinoshita, Kenneth R. Cooke, Melanie Grant, Maja Stanojevic, Conrad Russell Young Cruz, Michael Keller, Maria Fernanda Fortiz, Fahmida Hoq, Haili Lang, John Barrett, Hua Liang, Jay Tanna, Nan Zhang, Abeer Shibli, Anushree Datar, Kirsten M. Williams, Hema Dave, Jeffrey Dome, David Jacobsohn, Patrick Hanley, Richard J. Jones, Catherine M. Bollard
Journal: Blood
Blood (2021) 138 (Supplement 1): 2828.
https://doi.org/10.1182/blood-2021-153207
Published: 2021
Journal Articles

Access to CAR-T Cell Therapy in Underrepresented Populations: A Multicenter Cohort Study of Pediatric and Young Adult ALL Patients

Anurekha G. Hall, Lena E. Winestone, Erin M. Sullivan, Qian Vicky Wu, Adam J. Lamble, Mark C. Walters, Paibel Aguayo-Hiraldo, Lourdes Baez Conde, Tumaini R. Coker, Hema Dave, Dana Dornsife, Amy K. Keating, Diana M. Merino, Bonnie Ramsey, Julie R. Park, Anurag K. Agrawal
Journal: Blood
Blood (2021) 138 (Supplement 1): 339.
https://doi.org/10.1182/blood-2021-148256
Published: 2021
Journal Articles

Tumor Associated Antigen Specific T Cells Given in Combination with Nivolumab for the Treatment of Hodgkin Lymphoma

Hema Dave, MDMPH, Mimi Mai, Madeline Terpilowski, BS, Keri Toner, MD, Maja Stanojevic, MD, Morgan Galligan, BS, Abeer Shibli, BS, Melanie Grant, PhD, Christopher Lazarski, PhD, Philip Y Maglo, BS, MPH, Nan Zhang, PhD, Jay Tanna, MS, Richard F. Ambinder, MD, Martha Glenn, MD, Patrick Hanley, PhD, Catherine M. Bollard, MD MBChB
Journal: Blood
Blood (2020) 136 (Supplement 1): 18.
https://doi.org/10.1182/blood-2020-142422
Published: 2020
Journal Articles

Increased Tumor Specific Cytotoxic T Cell Responses and Reversion to a Favorable Cytokine Profile after Treatment in Patients with Newly Diagnosed High Risk Hodgkin Lymphoma Treated on Children's Oncology Group Trial-AHOD1331

Hema Dave, Mimi Mai, Anushree Datar, Gaye Jenkins, BS, Qinglin Pei, PhD, Yue Wu, MS, Frank G. Keller, MD, Sharon M. Castellino, MD MSc, Terzah M Horton, MD PhD, Catherine M. Bollard, MD MBChB
Journal: Blood
Blood (2020) 136 (Supplement 1): 41–42.
https://doi.org/10.1182/blood-2020-136376
Published: 2020